Locus Cell Co., Ltd. (TPEX:6891)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
85.60
+6.20 (7.81%)
Apr 29, 2026, 12:30 PM CST

Locus Cell Revenue

In the year 2025, Locus Cell had annual revenue of 12.74M TWD with 440.66% growth. Locus Cell had revenue of 9.28M in the half year ending December 31, 2025, with 2,186.70% growth.

Revenue
12.74M
Revenue Growth
+440.66%
P/S Ratio
1,246.96
Revenue / Employee
240.34K
Employees
53
Market Cap
15.88B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202512.74M10.38M440.66%
Dec 31, 20242.36M1.95M480.30%
Dec 31, 2023406.00K-194.00K-32.33%
Dec 31, 2022600.00K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TaiMed Biologics 611.35M
EirGenix 1.01B
Polaris Group 40.60M
Ever Supreme Bio Technology 1.02B
CHO Pharma 1.43M
Medigen Vaccine Biologics 613.17M
Tanvex BioPharma 400.97M
AP Biosciences 32.25M
Revenue Rankings